These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10487548)

  • 1. Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer.
    Fisher BJ; Perera FE; Kocha W; Tomiak A; Taylor M; Vincent M; Bauman GS
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):291-5. PubMed ID: 10487548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.
    Park JK; Ryu JK; Lee JK; Yoon WJ; Lee SH; Kim YT; Yoon YB
    Pancreas; 2006 Nov; 33(4):397-402. PubMed ID: 17079946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
    Burris HA; Moore MJ; Andersen J; Green MR; Rothenberg ML; Modiano MR; Cripps MC; Portenoy RK; Storniolo AM; Tarassoff P; Nelson R; Dorr FA; Stephens CD; Von Hoff DD
    J Clin Oncol; 1997 Jun; 15(6):2403-13. PubMed ID: 9196156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.
    Brasiūnas V; Brasiūniene B; Juozaityte E; Barauskas G
    Medicina (Kaunas); 2004; 40(11):1074-80. PubMed ID: 15547308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer.
    Shinchi H; Takao S; Noma H; Matsuo Y; Mataki Y; Mori S; Aikou T
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):146-50. PubMed ID: 12007953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
    Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
    J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.
    Wong AA; Delclos ME; Wolff RA; Evans DB; Abbruzzese JL; Tamm EP; Xiong HQ; Ho L; Crane CH;
    Am J Clin Oncol; 2005 Jun; 28(3):227-33. PubMed ID: 15923793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study.
    Bai YR; Wu GH; Guo WJ; Wu XD; Yao Y; Chen Y; Zhou RH; Lu DQ
    World J Gastroenterol; 2003 Nov; 9(11):2561-4. PubMed ID: 14606097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil.
    Mawdsley S; Hall M; Glynne-Jones R
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):308-12. PubMed ID: 12206644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
    Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
    Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
    Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
    Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
    Rothenberg ML; Moore MJ; Cripps MC; Andersen JS; Portenoy RK; Burris HA; Green MR; Tarassoff PG; Brown TD; Casper ES; Storniolo AM; Von Hoff DD
    Ann Oncol; 1996 Apr; 7(4):347-53. PubMed ID: 8805925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.
    Azria D; Ychou M; Jacot W; Thezenas S; Lemanski C; Senesse P; Prost P; Delard R; Masson B; Dubois JB
    Pancreas; 2002 Nov; 25(4):360-5. PubMed ID: 12409830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
    Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer.
    Klein B; Sadikov E; Mishaeli M; Levin I; Figer A
    Oncol Rep; 2000; 7(4):875-7. PubMed ID: 10854561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for resectable and advanced pancreatic cancer.
    Berlin JD; Rothenberg M
    Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.